Psychedelic researcher Matthew W. Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine, recently received a grant from the National Institute on Drug Abuse (NIDA) to study psilocybin for tobacco addiction.
“To my knowledge it’s the 1st grant from the U.S. government in over a half century to directly study therapeutics of a classic psychedelic,” wrote Johnson on Twitter.
The trials will take place at the University of Alabama at Birmingham (site leader Peter Hendricks) and New York University (site leader Michael Bogenschutz).
